{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:28:40Z","timestamp":1761647320077},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"951","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There is a plausible biological basis for the association between psychiatric morbidity and cardiovascular disease. Anxiety, panic disorder, and depression are common in patients with coronary heart disease and hypertension. Despite this evidence there is poor recognition of anxiety disorders and depression in primary care and hospital medical practice. Concern also surrounds the use of psychotropic drugs in patients with cardiovascular disease. In the first of the two articles on this subject, we highlighted the current evidence regarding the association between cardiovascular and psychotropic conditions. In this second article, we discuss the interaction of the drugs used in the management of these two varied but commonly coexistent group of diseases as well as their relative effects on either system. Finally, we summarise the data regarding the safe use of these medications based on the recommendations from the currently available evidence.<\/jats:p>","DOI":"10.1136\/pgmj.2003.015230","type":"journal-article","created":{"date-parts":[[2005,1,7]],"date-time":"2005-01-07T21:03:06Z","timestamp":1105131786000},"page":"33-40","source":"Crossref","is-referenced-by-count":16,"title":["Heart and mind: (2) psychotropic and cardiovascular therapeutics"],"prefix":"10.1093","volume":"81","author":[{"given":"S U","family":"Shah","sequence":"first","affiliation":[{"name":"University Hospital Birmingham and University of Birmingham , Birmingham , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ysbyty Gwynedd , Bangor, North Wales , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"White","sequence":"additional","affiliation":[{"name":"University Hospital Birmingham , Birmingham , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"White","sequence":"additional","affiliation":[{"name":"University Hospital Birmingham , Birmingham , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,1,7]]},"reference":[{"key":"2023042408153520200_R1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/pgmj.2003.014662","article-title":"Heart and mind: (1) relationship between cardiovascular and psychiatric conditions","volume":"80","author":"Shah","year":"2004","journal-title":"Postgrad Med J"},{"key":"2023042408153520200_R2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","article-title":"The global burden of disease, 1990\u20132020","volume":"4","author":"Lopez","year":"1998","journal-title":"Nat Med"},{"key":"2023042408153520200_R3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0920-9964(92)90040-C","article-title":"Mortality in DSM\u2013III\u2013R schizophrenia","volume":"7","author":"Black","year":"1992","journal-title":"Schizophr Res"},{"key":"2023042408153520200_R4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archpsyc.1978.01770340031002","volume":"35","author":"Tsuang","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"2023042408153520200_R5"},{"key":"2023042408153520200_R6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/070674379103600401","article-title":"Mortality in a cohort of patients with schizophrenia: a record linkage study","volume":"36","author":"Newman","year":"1991","journal-title":"Can J Psychiatry"},{"key":"2023042408153520200_R7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/bmj.305.6853.538","article-title":"Unexplained death in fit young people","volume":"305","author":"Davies","year":"1992","journal-title":"BMJ"},{"key":"2023042408153520200_R8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/01.CIR.51.4.606","article-title":"Precursors of sudden coronary death. Factors related to the incidence of sudden death","volume":"51","author":"Kannel","year":"1975","journal-title":"Circulation"},{"key":"2023042408153520200_R9","first-page":"2","volume":"22","author":"Committee on Safety of Medicines. Drug-induced prolongation of the QT interval","year":"1996","journal-title":"Current Problems in Pharmacovigilance"},{"key":"2023042408153520200_R10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0002-8703(65)90373-X","article-title":"Electrocardiographic changes induced by phenothiazine drugs","volume":"70","author":"Ban","year":"1965","journal-title":"Am Heart J"},{"key":"2023042408153520200_R11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/jama.1966.03110140066019","article-title":"The effects of thioridazine hydrochloride and chlorpromazine on the electrocardiogram","volume":"198","author":"Huston","year":"1966","journal-title":"JAMA"},{"key":"2023042408153520200_R12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0002-8703(69)90442-6","article-title":"Cardiovascular complications in young patients taking psychotropic drugs","volume":"78","author":"Alexander","year":"1969","journal-title":"Am Heart J"},{"key":"2023042408153520200_R13","first-page":"1","article-title":"Cardiovascular effects of phenothiazines","volume":"V","author":"Ayd","year":"1970","journal-title":"International Drug Therapy Newsletter"},{"key":"2023042408153520200_R14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/070674376901400514","article-title":"Phenothiazine treatment and electrocardiographic abnormalities","volume":"14","author":"Lapierre","year":"1969","journal-title":"Canadian Psychiatric Association Journal"},{"key":"2023042408153520200_R15","first-page":"534","article-title":"Cardiac toxicity and psychotropic drugs","volume":"31","author":"Crane","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"2023042408153520200_R16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/pgmj.51.592.65","article-title":"Phenothiazines and the electrocardiogram","volume":"51","author":"Raj","year":"1975","journal-title":"Postgrad Med J"},{"key":"2023042408153520200_R17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0002-9149(76)90316-7","article-title":"Electrocardiographic changes and cardiacarrhythmias in patients receiving psychotropic drugs","volume":"37","author":"Fowler","year":"1976","journal-title":"Am J Cardiol"},{"key":"2023042408153520200_R18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-197714010-00002","article-title":"Drug-induced cardiovascular diseases","volume":"14","author":"Deglin","year":"1977","journal-title":"Drugs"},{"key":"2023042408153520200_R19","volume-title":"Stress and the heart","author":"Wheatley","year":"1981"},{"key":"2023042408153520200_R20","first-page":"69","article-title":"Cardiac side-effects and sudden death in hospitalized psychiatricpatients","volume":"38","author":"Swett","year":"1977","journal-title":"Diseases of the Nervous System"},{"key":"2023042408153520200_R21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.1996.tb10653.x","article-title":"Electrocardiographic changes in patients receiving neuroleptic medication","volume":"93","author":"Warner","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"2023042408153520200_R22","first-page":"199","article-title":"Cardiotoxicity more common in thioridazine overdose than with other neuroleptics","volume":"33","author":"Buckley","year":"1995","journal-title":"Clinical Toxicology"},{"key":"2023042408153520200_R23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1192\/bjp.165.6.787","article-title":"Post-mortem antipsychotic drug concentrations and unexplained deaths","volume":"165","author":"Jusic","year":"1994","journal-title":"Br J Psychiatry"},{"key":"2023042408153520200_R24","first-page":"77","article-title":"Drugs, QT interval abnormalities and ventricular arrhythmias","volume":"13","author":"Thomas","year":"1994","journal-title":"Adverse Drug Reactions and Toxicology Review"},{"key":"2023042408153520200_R25","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1176\/ajp.144.5.673","article-title":"EEG changes during haloperidol and pimozide treatment of Tourette\u2019s disorder","volume":"144","author":"Fulop","year":"1987","journal-title":"Am J Psychiatry"},{"key":"2023042408153520200_R26","first-page":"2","article-title":"Cardiac arrhythmias with pimozide (Orap)","volume":"21","author":"Committee on Safety of Medicines","year":"1995","journal-title":"Current Problems in Pharmacovigilance"},{"key":"2023042408153520200_R27","first-page":"221","article-title":"Antibody phenothiazines. Multiple antibody screening of patients under high doses","volume":"8","author":"Guillan","year":"1977","journal-title":"Journal of the Kansas Medical Society"},{"key":"2023042408153520200_R28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/jat\/16.1.54","article-title":"Clozapine tissue concentrations following an apparent suicidal overdose of clozaril","volume":"16","author":"Meeker","year":"1992","journal-title":"J Anal Toxicol"},{"key":"2023042408153520200_R29","first-page":"4151","article-title":"Allergic myocarditis in clozapine treatment","volume":"156","author":"Jensen","year":"1994","journal-title":"Ugeskr Laeger"},{"key":"2023042408153520200_R30","first-page":"3026","article-title":"Clozapine and myocarditis","volume":"115","author":"Lilleng","year":"1995","journal-title":"Tidsskr Nor Laegeforen"},{"key":"2023042408153520200_R31","author":"Office of Population Censuses and Surveys","year":"1992"},{"key":"2023042408153520200_R32","first-page":"931","volume-title":"Textbook of psychopharmacology","author":"Stoudemire","year":"1998"},{"key":"2023042408153520200_R33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00005344-199407000-00010","article-title":"Antiischemic effects of intravenous diazepam in patients with coronary artery disease","volume":"24","author":"Rossetti","year":"1994","journal-title":"J Cardiovasc Pharmacol"},{"key":"2023042408153520200_R34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0033-3182(90)72132-9","article-title":"Psychotropic drug use in the medically ill","volume":"31","author":"Stoudemire","year":"1990","journal-title":"Psychosomatics"},{"key":"2023042408153520200_R35","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0033-3182(98)71339-8","article-title":"Psychopharmacologic treatment of depression in the medically ill","volume":"39","author":"Beliles","year":"1998","journal-title":"Psychosomatics"},{"key":"2023042408153520200_R36","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.1993.03500200087039","article-title":"The safety of tricyclic antidepressants in cardiac patients: risk-benefit reconsidered","volume":"269","author":"Glassman","year":"1993","journal-title":"JAMA"},{"key":"2023042408153520200_R37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of enacinide and flecainide on mortality in a randomised trial of arrhythmia suppression after myocardial infarction","volume":"321","author":"Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","journal-title":"N Engl J Med"},{"key":"2023042408153520200_R38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the anti arrhythmic agent moricizine on survival after myocardial infarction","volume":"327","author":"Cardiac Arrhythmia Suppression Trial II Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"2023042408153520200_R39","first-page":"16","article-title":"Review of the cardiovascular effects of heterocyclic antidepressants","volume":"54","author":"Glassman","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"2023042408153520200_R40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00004714-198504000-00009","article-title":"Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients","volume":"5","author":"Neshkes","year":"1985","journal-title":"J Clin Psychopharmacol"},{"key":"2023042408153520200_R41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/ajp.148.4.512","article-title":"Cardiovascular effects of bupropion in depressed patients with heart disease","volume":"148","author":"Roose","year":"1991","journal-title":"Am J Psychiatry"},{"key":"2023042408153520200_R42","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1176\/ajp.156.7.1024","article-title":"Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease","volume":"156","author":"Nelson","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2023042408153520200_R43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1176\/ajp.155.5.660","article-title":"Cardiovascular effects of fluoxetine in depressed patients with heart disease","volume":"155","author":"Roose","year":"1998","journal-title":"Am J Psychiatry"},{"key":"2023042408153520200_R44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00004714-199608000-00002","article-title":"Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. I","volume":"16","author":"Harvey","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"2023042408153520200_R45","first-page":"574","article-title":"Cardiovascular safety in depressed patients: focus on venlafaxine","volume":"56","author":"Feighner","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"2023042408153520200_R46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0033-3182(91)72109-9","article-title":"Psychotropic drug use in the medically ill: II","volume":"32","author":"Stoudemire","year":"1991","journal-title":"Psychosomatics"},{"key":"2023042408153520200_R47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0033-3182(95)71609-7","article-title":"The association between intravenous haloperidol and torsades de pointes","volume":"36","author":"Hunt","year":"1995","journal-title":"Psychosomatics"},{"key":"2023042408153520200_R48","first-page":"38","article-title":"Maximizing clozapine therapy: managing side-effects","volume":"59","author":"Lieberman","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"2023042408153520200_R49","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet"},{"key":"2023042408153520200_R50","first-page":"336","article-title":"Lithium- and carbamazepine-associated sinus node dysfunction: nine-year experience in a psychiatric hopsital","volume":"14","author":"Stekler","year":"1994","journal-title":"J Clin Psychopharmacol"},{"key":"2023042408153520200_R51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2165\/00003495-199447020-00008","article-title":"Valproate. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"2023042408153520200_R52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ana.410220217","article-title":"Carbamazepine and cardiac conduction disturbances","volume":"22","author":"Benassi","year":"1999","journal-title":"Ann Neurol"},{"key":"2023042408153520200_R53","first-page":"58","article-title":"Clinical pharmacokinetics of carbamazepine","volume":"49","author":"Levy","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"2023042408153520200_R54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1528-1157.1994.tb02930.x","article-title":"Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review","volume":"35","author":"Van Amelsvoort","year":"1994","journal-title":"Epilepsia"},{"key":"2023042408153520200_R55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00003088-199631030-00004","article-title":"Clinically significant pharmacokinetic drug interactions with carbamazepine. An update","volume":"31","author":"Spina","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"2023042408153520200_R56","first-page":"351","volume-title":"The American Psychiatric Press textbook of psychopharmacology","author":"McElroy","year":"1995"},{"key":"2023042408153520200_R57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00003495-199346030-00007","article-title":"Gabapentin","volume":"46","author":"Goa","year":"1993","journal-title":"Drugs"},{"key":"2023042408153520200_R58","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003495-199550040-00008","article-title":"Lamotrigine: an update of its pharmacology and therapeutic use in epilepsy","volume":"50","author":"Fitton","year":"1995","journal-title":"Drugs"},{"key":"2023042408153520200_R59","first-page":"305","article-title":"Central nervous systems considerations in the use of beta-blockers, angiotension-converting enzyme inhibitors and thiazide diuretics in managing essential hypertension","volume":"116","author":"Gengo","year":"1988","journal-title":"Am J Cardiol"},{"key":"2023042408153520200_R60","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/archinte.1990.00390220044009","article-title":"Increased prescribing of antidepressants subsequent to beta-blocker therapy","volume":"150","author":"Thiessen","year":"1990","journal-title":"Arch Intern Med"},{"key":"2023042408153520200_R61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-8703(88)90627-8","article-title":"Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases","volume":"116","author":"Houston","year":"1988","journal-title":"Am Heart J"},{"key":"2023042408153520200_R62","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/0002-8703(91)90144-7","article-title":"Digitalis and beta-blocking agents: effects on depression following myocardial infarction","volume":"121","author":"Schleifer","year":"1991","journal-title":"Am Heart J"},{"key":"2023042408153520200_R63","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1176\/ajp.144.4.506","article-title":"Toxic neuropsychiatric effects of digoxin at therapeutic serum concentrations","volume":"144","author":"Eisendrath","year":"1987","journal-title":"Am J Psychiatry"},{"key":"2023042408153520200_R64","first-page":"539","volume-title":"Psychiatric care of the medical patient","author":"Levenson","year":"1993"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/81\/951\/33\/50025260\/postgradmedj-81-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/81\/951\/33\/50025260\/postgradmedj-81-33.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:17:58Z","timestamp":1682324278000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/81\/951\/33\/7031811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":64,"journal-issue":{"issue":"951","published-online":{"date-parts":[[2005,1,7]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2003.015230","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,1]]},"published":{"date-parts":[[2005,1,1]]}}}